Related Experiment Video
Updated: Sep 21, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling
S Dauvois1, R White, M G Parker
1Molecular Endocrinology Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK.
Abstract:
The mouse estrogen receptor was shown to be constantly shuttling between the nucleus and cytoplasm although under steady-state conditions it is detected predominantly in the cell nucleus in both the absence and presence of estradiol. Shuttling was demonstrated by monitoring the transfer of protein between nuclei in heterokaryons and by examining the subcellular distribution of mutant receptors. In the presence of the partial antiestrogen 4-hydroxytamoxifen the receptor was retained in the nucleus whereas it accumulated in the cytoplasm when cells were treated with the pure antiestrogen ICI 182780. The effect of the pure antiestrogen was to inhibit nucleocytoplasmic shuttling of the receptor by blocking its nuclear uptake. Thus although ligand binding is not required by the estrogen receptor to undergo nucleocytoplasmic shuttling, this process can be disrupted by the binding of a pure antiestrogen.
Insights
The mouse estrogen receptor continuously moves between the nucleus and cytoplasm. Pure antiestrogens block this shuttling by preventing nuclear entry, impacting estrogen receptor function.
Area of Science:
- Molecular Biology
- Cell Biology
- Endocrinology
Background:
- The estrogen receptor (ER) plays a crucial role in cellular processes.
- Understanding ER's subcellular localization and dynamics is key to its function.
- ER shuttling between the nucleus and cytoplasm influences gene regulation.
Purpose of the Study:
- To investigate the nucleocytoplasmic shuttling of the mouse estrogen receptor.
- To determine the effect of estradiol and antiestrogens on ER localization.
- To elucidate the mechanism by which antiestrogens affect ER shuttling.
Main Methods:
- Heterokaryon assays to monitor protein transfer between nuclei.
- Analysis of subcellular distribution of wild-type and mutant estrogen receptors.
- Treatment with estradiol, 4-hydroxytamoxifen (partial antiestrogen), and ICI 182780 (pure antiestrogen).
Main Results:
- Estrogen receptor exhibits constant nucleocytoplasmic shuttling, predominantly residing in the nucleus at steady-state.
- The partial antiestrogen 4-hydroxytamoxifen retained the receptor in the nucleus.
- The pure antiestrogen ICI 182780 caused cytoplasmic accumulation by inhibiting nuclear uptake, thus blocking shuttling.
- Ligand binding is not essential for ER shuttling but can be disrupted by pure antiestrogens.
Conclusions:
- Estrogen receptor shuttling is an intrinsic property independent of ligand binding.
- Pure antiestrogens like ICI 182780 disrupt ER function by inhibiting nucleocytoplasmic transport.
- Understanding ER dynamics provides insights into endocrine signaling and therapeutic strategies.
Related Concept Videos
Internal Receptors
Regulation of Nuclear Protein Sorting
Experimental RNAi
Inhibition of Cdk Activity
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

